Expert Roundtable on the Current and Near Future Impact of Novel Therapeutic Options for Relapsed/Refractory CLL/SLL

Download the slideset, watch the on-demand webcast, and read faculty responses to questions from a live webinar where experts discuss the latest data on novel therapies for R/R CLL/SLL and their current and potential impact on clinical practice.

Share

Program Content

Activities

Novel BTKi in CLL
The Current and Potential Role of Novel BTK Inhibitors in R/R CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2023

View Activity
CAR T for CLL
Emerging CAR T-Cell Therapy for CLL/SLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2023

View Activity

Activities

CLL SLL expert roundtable
Expert Roundtable: Impact of Novel Therapies in Relapsed/Refractory CLL/SLL
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2023

Expires: November 19, 2024

View Activity

Activities

Novel BTKi for CLL/SLL
Our Experiences and Considerations With Current and Emerging BTK Inhibitors for R/R CLL/SLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2023

View Activity

Faculty

cover img faculity

Jennifer R. Brown, MD, PhD

Director, CLL Center & Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Boston, Massachusetts

cover img faculity

Florence Cymbalista, MD, PhD

Professor of Hematology
Sorbonne Paris Nord University
Bobigny, France

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Lilly and Merck Sharp & Dohme, LLC.

Lilly

Merck Sharp & Dohme, LLC